comparemela.com

Latest Breaking News On - Clorox healthcare - Page 3 : comparemela.com

Wilkins Investment Counsel Inc Purchases 350 Shares of The Clorox Company (NYSE:CLX)

Wilkins Investment Counsel Inc. boosted its holdings in The Clorox Company (NYSE:CLX – Free Report) by 3.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,890 shares of the company’s stock after buying an additional 350 shares during the period. […]

The Clorox Company (NYSE:CLX) Receives $146 43 Consensus Target Price from Analysts

The Clorox Company (NYSE:CLX – Get Free Report) has received a consensus recommendation of “Reduce” from the sixteen analysts that are presently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a sell recommendation and twelve have given a hold recommendation to the company. The average twelve-month target price among brokerages […]

The Clorox Company (NYSE:CLX) Receives Average Recommendation of Reduce from Brokerages

The Clorox Company (NYSE:CLX – Get Free Report) has received an average rating of “Reduce” from the sixteen brokerages that are covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a sell recommendation and twelve have given a hold recommendation to the company. The average twelve-month price objective among brokers that […]

Stifel Financial Corp Grows Stock Position in The Clorox Company (NYSE:CLX)

Stifel Financial Corp lifted its stake in The Clorox Company (NYSE:CLX – Free Report) by 0.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,185,941 shares of the company’s stock after purchasing an additional 1,066 shares during the period. Stifel Financial […]

The Clorox Company (NYSE:CLX) Receives $146 43 Average Price Target from Brokerages

Shares of The Clorox Company (NYSE:CLX – Get Free Report) have been assigned a consensus rating of “Reduce” from the sixteen brokerages that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a sell rating and twelve have given a hold rating to the company. The average 12-month price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.